Kelly R. Knight, Ph.D. - Publications

Affiliations: 
2010 Medical Anthropology University of California, San Francisco, San Francisco, CA 
Area:
Medical and Forensic Anthropology, Women's Studies, Mental Health

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Aronowitz SV, Carroll JJ, Hansen H, Jauffret-Roustide M, Parker CM, Suhail-Sindhu S, Albizu-Garcia C, Alegria M, Arrendondo J, Baldacchino A, Bluthental R, Bourgois P, Burraway J, Chen JS, Ekhtiari H, ... ... Knight K, et al. Substance use policy and practice in the COVID-19 pandemic: Learning from early pandemic responses through internationally comparative field data. Global Public Health. 1-16. PMID 36692903 DOI: 10.1080/17441692.2022.2129720  0.607
2020 Behar E, Bagnulo R, Knight K, Santos GM, Coffin PO. "Chasing the pain relief, not the high": Experiences managing pain after opioid reductions among patients with HIV and a history of substance use. Plos One. 15: e0230408. PMID 32210442 DOI: 10.1371/Journal.Pone.0230408  0.322
2019 Satterwhite S, Knight KR, Miaskowski C, Chang JS, Ceasar R, Zamora K, Kushel M. Sources and Impact of Time Pressure on Opioid Management in the Safety-Net. Journal of the American Board of Family Medicine : Jabfm. 32: 375-382. PMID 31068401 DOI: 10.3122/Jabfm.2019.03.180306  0.303
2017 Knight KR. Women on the Edge: Opioids, Benzodiazepines, and the Social Anxieties Surrounding Women's Reproduction in the U.S. "Opioid Epidemic". Contemporary Drug Problems. 44: 301-320. PMID 31537950 DOI: 10.1177/0091450917740359  0.36
2017 Knight KR, Kushel M, Chang JS, Zamora K, Ceasar R, Hurstak E, Miaskowski C. Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use. Social Science & Medicine (1982). 186: 87-95. PMID 28599142 DOI: 10.1016/J.Socscimed.2017.05.043  0.352
2017 Hurstak EE, Kushel M, Chang J, Ceasar R, Zamora K, Miaskowski C, Knight K. The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics. Substance Abuse. 1-9. PMID 28394752 DOI: 10.1080/08897077.2017.1296524  0.314
2016 Chang JS, Kushel M, Miaskowski C, Ceasar R, Zamora K, Hurstak E, Knight KR. Provider Experiences With the Identification, Management, and Treatment of Co-occurring Chronic Noncancer Pain and Substance Use in the Safety Net. Substance Use & Misuse. 1-5. PMID 27754719 DOI: 10.1080/10826084.2016.1223138  0.306
2015 Ceasar R, Chang J, Zamora K, Hurstak E, Kushel M, Miaskowski C, Knight K. Primary Care Providers' Experiences with Urine Toxicology Tests to Manage Prescription Opioid Misuse and Substance Use Among Chronic Non-Cancer Pain Patients in Safety Net Healthcare Settings. Substance Abuse. 0. PMID 26682471 DOI: 10.1080/08897077.2015.1132293  0.323
2015 Mizuno Y, Purcell DW, Knowlton AR, Wilkinson JD, Gourevitch MN, Knight KR. Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users. Aids and Behavior. 19: 684-93. PMID 25249392 DOI: 10.1007/S10461-014-0890-0  0.368
2015 Knight KR. addicted.pregnant.poor Materials. 3: 163. DOI: 10.1215/9780822375180  0.328
2014 Riley ED, Cohen J, Knight KR, Decker A, Marson K, Shumway M. Recent violence in a community-based sample of homeless and unstably housed women with high levels of psychiatric comorbidity. American Journal of Public Health. 104: 1657-63. PMID 25033127 DOI: 10.2105/Ajph.2014.301958  0.304
2014 Knight KR, Das M, DeMicco E, Raiford JL, Matheson T, Shook A, Antunez E, Santos GM, Dadasovich R, Dilley JW, Colfax GN, Herbst JH. A roadmap for adapting an evidence-based HIV prevention intervention: personal cognitive counseling (PCC) for episodic substance-using men who have sex with men. Prevention Science : the Official Journal of the Society For Prevention Research. 15: 364-75. PMID 23412947 DOI: 10.1007/S11121-013-0364-Z  0.381
2012 Mackenzie S, Pearson C, Frye V, Gómez CA, Latka MH, Purcell DW, Knowlton AR, Metsch LR, Tobin KE, Valverde EE, Knight KR. Agents of change: peer mentorship as HIV prevention among HIV-positive injection drug users. Substance Use & Misuse. 47: 522-34. PMID 22428820 DOI: 10.3109/10826084.2012.644122  0.38
2010 Rose CD, Courtenay-Quirk C, Knight K, Shade SB, Vittinghoff E, Gomez C, Lum PJ, Bacon O, Colfax G. HIV intervention for providers study: A randomized controlled trial of a clinician-delivered HIV risk-reduction intervention for HIV-positive people Journal of Acquired Immune Deficiency Syndromes. 55: 572-581. PMID 20827218 DOI: 10.1097/Qai.0B013E3181Ee4C62  0.368
2009 Mizuno Y, Purcell DW, Zhang J, Knowlton AR, De Varona M, Arnsten JH, Knight KR. Predictors of current housing status among HIV-seropositive injection drug users (IDUs): results from a 1-year study. Aids and Behavior. 13: 165-72. PMID 18247113 DOI: 10.1007/S10461-008-9364-6  0.403
2008 Latkin CA, Buchanan AS, Metsch LR, Knight K, Latka MH, Mizuno Y, Knowlton AR. Predictors of sharing injection equipment by HIV-seropositive injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 49: 447-50. PMID 19186356 DOI: 10.1097/Qai.0B013E31818A6546  0.41
2007 Knight KR, Shade SB, Purcell DW, Rose CD, Metsch LR, Latka MH, Latkin CA, Gómez CA. Sexual transmission risk behavior reported among behaviorally bisexual HIV-positive injection drug-using men. Journal of Acquired Immune Deficiency Syndromes (1999). 46: S80-7. PMID 18089988 DOI: 10.1097/Qai.0B013E3181576828  0.376
2007 Arnsten JH, Li X, Mizuno Y, Knowlton AR, Gourevitch MN, Handley K, Knight KR, Metsch LR. Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 46: S64-71. PMID 18089986 DOI: 10.1097/Qai.0B013E31815767D6  0.317
2007 Purcell DW, Latka MH, Metsch LR, Latkin CA, Gómez CA, Mizuno Y, Arnsten JH, Wilkinson JD, Knight KR, Knowlton AR, Santibanez S, Tobin KE, Rose CD, Valverde EE, Gourevitch MN, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 46: S35-47. PMID 18089983 DOI: 10.1097/Qai.0B013E31815767C4  0.375
2007 Frye V, Latka MH, Wu Y, Valverde EE, Knowlton AR, Knight KR, Arnsten JH, O'Leary A. Intimate partner violence perpetration against main female partners among HIV-positive male injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 46: S101-9. PMID 18089979 DOI: 10.1097/Qai.0B013E31815767E6  0.397
2006 Purcell DW, Mizuno Y, Metsch LR, Garfein R, Tobin K, Knight K, Latka MH. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 83: 656-68. PMID 16736116 DOI: 10.1007/S11524-006-9066-1  0.374
2006 Missildine W, Parsons JT, Knight K. Split ends: Masculinity, sexuality and emotional intimacy among HIV-positive heterosexual men Men and Masculinities. 8: 309-320. DOI: 10.1177/1097184X05282079  0.313
2005 Knight KR, Purcell D, Dawson-Rose C, Halkitis PN, Gomez CA. Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 17: 76-88. PMID 15843119 DOI: 10.1521/Aeap.17.2.76.58692  0.403
2005 Comfort M, Grinstead O, McCartney K, Bourgois P, Knight K. "You cannot do nothing in this damn place": sex and intimacy among couples with an incarcerated male partner. Journal of Sex Research. 42: 3-12. PMID 15795799 DOI: 10.1080/00224490509552251  0.353
2003 Mizuno Y, Purcell D, Borkowski TM, Knight K. The life priorities of HIV-seropositive injection drug users: findings from a community-based sample. Aids and Behavior. 7: 395-403. PMID 14707536 DOI: 10.1023/B:Aibe.0000004731.94734.77  0.367
2001 Downing M, Knight K, Reiss TH, Vernon K, Mulia N, Ferreboeuf M, Carroll A, Vu C. Drug users talk about HIV testing: motivating and deterring factors. Aids Care-Psychological and Socio-Medical Aspects of Aids\/Hiv. 13: 561-577. PMID 11571004 DOI: 10.1080/09540120120063205  0.381
2001 Vernon KA, Mulia N, Downing M, Knight K, Reiss T. “I don't know when it might pop up”: Understanding repeat HIV testing and perceptions of HIV among drug users Journal of Substance Abuse. 13: 215-227. PMID 11547621 DOI: 10.1016/S0899-3289(01)00067-0  0.373
1998 Van Der Straten A, Vernon KA, Knight KR, Gómez CA, Padian NS. Managing HIV among serodiscordant heterosexual couples: Serostatus, stigma and sex Aids Care - Psychological and Socio-Medical Aspects of Aids/Hiv. 10: 533-548. PMID 9828951 DOI: 10.1080/09540129848406  0.37
1996 Rosenbaum M, Washbum A, Knight K, Kelley MS, Irwin J. Treatment as harm reduction, defunding as harm maximization: the case of methadone maintenance. Journal of Psychoactive Drugs. 28: 241-249. PMID 8895109 DOI: 10.1080/02791072.1996.10472485  0.376
1996 Knight KR, Rosenbaum M, Irwin J, Kelley MS, Wenger L, Washburn A. Involuntary versus voluntary detoxification from methadone maintenance treatment: The importance of choice Addiction Research and Theory. 3: 351-362. DOI: 10.3109/16066359609005248  0.307
1996 Knight KR, Rosenbaum M, Kelley MS, Irwin J, Washburn A, Wenger L. Defunding the poor: The impact of lost access to subsidized methadone maintenance treatment on women injection drug users Journal of Drug Issues. 26: 923-942. DOI: 10.1177/002204269602600411  0.317
1996 Kelley MS, Rosenbaum M, Knight K, Irwin J, Washburn A. Violence: A Barrier To Methadone Maintenance Treatment For Women Injection Drug Users International Journal of Sociology and Social Policy. 16: 156-177. DOI: 10.1108/Eb013260  0.331
Show low-probability matches.